309 related articles for article (PubMed ID: 34111497)
1. Guidelines of care for the management of actinic keratosis: Executive summary.
Eisen DB; Asgari MM; Bennett DD; Connolly SM; Dellavalle RP; Freeman EE; Goldenberg G; Leffell DJ; Peschin S; Sligh JE; Wu PA; Frazer-Green L; Malik S; Schlesinger TE
J Am Acad Dermatol; 2021 Oct; 85(4):945-955. PubMed ID: 34111497
[TBL] [Abstract][Full Text] [Related]
2. Guidelines of care for the management of actinic keratosis.
Eisen DB; Asgari MM; Bennett DD; Connolly SM; Dellavalle RP; Freeman EE; Goldenberg G; Leffell DJ; Peschin S; Sligh JE; Wu PA; Frazer-Green L; Malik S; Schlesinger TE
J Am Acad Dermatol; 2021 Oct; 85(4):e209-e233. PubMed ID: 33820677
[TBL] [Abstract][Full Text] [Related]
3. Focused update: Guidelines of care for the management of actinic keratosis.
Eisen DB; Dellavalle RP; Frazer-Green L; Schlesinger TE; Shive M; Wu PA
J Am Acad Dermatol; 2022 Aug; 87(2):373-374.e5. PubMed ID: 35439607
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the Treatment Guidelines for Actinic Keratosis: A Critical Appraisal and Review.
Fleming P; Zhou S; Bobotsis R; Lynde C
J Cutan Med Surg; 2017; 21(5):408-417. PubMed ID: 28510496
[TBL] [Abstract][Full Text] [Related]
5. Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.
Poulin Y; Lynde CW; Barber K; Vender R; Claveau J; Bourcier M; Ashkenas J;
J Cutan Med Surg; 2015; 19(3):227-38. PubMed ID: 25926621
[TBL] [Abstract][Full Text] [Related]
6. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.
Jansen MHE; Kessels JPHM; Merks I; Nelemans PJ; Kelleners-Smeets NWJ; Mosterd K; Essers BAB
Br J Dermatol; 2020 Oct; 183(4):738-744. PubMed ID: 31961446
[TBL] [Abstract][Full Text] [Related]
7. Solar keratoses: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Schmitt AR; Bordeaux JS
Clin Dermatol; 2013; 31(6):712-7. PubMed ID: 24160275
[TBL] [Abstract][Full Text] [Related]
8. Contemporary management of actinic keratosis.
Navarrete-Dechent C; Marghoob AA; Marchetti MA
J Dermatolog Treat; 2021 Aug; 32(5):572-574. PubMed ID: 31621454
[TBL] [Abstract][Full Text] [Related]
9. Actinic Keratosis: Current Therapies and Insights Into New Treatments.
Hashim PW; Chen T; Rigel D; Bhatia N; Kircik LH
J Drugs Dermatol; 2019 May; 18(5):s161-166.. PubMed ID: 31141862
[TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of interventions for actinic keratosis: protocol for a systematic review and network meta-analysis.
Steeb T; Heppt MV; Becker L; Kohl C; French LE; Berking C
Syst Rev; 2019 Oct; 8(1):237. PubMed ID: 31604446
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Hasan ZU; Ahmed I; Matin RN; Homer V; Lear JT; Ismail F; Whitmarsh T; Green AC; Thomson J; Milligan A; Hogan S; Van-de-Velde V; Mitchell-Worsford L; Kentley J; Gaunt C; Jefferson-Hulme Y; Bowden SJ; Gaunt P; Wheatley K; Proby CM; Harwood CA
Br J Dermatol; 2022 Sep; 187(3):324-337. PubMed ID: 34988975
[TBL] [Abstract][Full Text] [Related]
12. Actinic keratosis - review for clinical practice.
de Oliveira ECV; da Motta VRV; Pantoja PC; Ilha CSO; Magalhães RF; Galadari H; Leonardi GR
Int J Dermatol; 2019 Apr; 58(4):400-407. PubMed ID: 30070357
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Long-term Clearance Rates of Interventions for Actinic Keratosis: A Systematic Review and Network Meta-analysis.
Steeb T; Wessely A; Petzold A; Brinker TJ; Schmitz L; Leiter U; Garbe C; Schöffski O; Berking C; Heppt MV
JAMA Dermatol; 2021 Sep; 157(9):1066-1077. PubMed ID: 34347015
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review.
Arcuri D; Ramchatesingh B; Lagacé F; Iannattone L; Netchiporouk E; Lefrançois P; Litvinov IV
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902419
[TBL] [Abstract][Full Text] [Related]
15. Treatment options for actinic keratoses.
McIntyre WJ; Downs MR; Bedwell SA
Am Fam Physician; 2007 Sep; 76(5):667-71. PubMed ID: 17894135
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of randomized controlled trials of topicals for actinic keratosis field therapy.
Patel P; Wang J; Bitterman D; Mineroff J; Austin E; Jagdeo J
Arch Dermatol Res; 2024 Mar; 316(4):108. PubMed ID: 38498070
[TBL] [Abstract][Full Text] [Related]
17. Treatment of actinic keratosis: a systematic review.
Worley B; Harikumar V; Reynolds K; Dirr MA; Christensen RE; Anvery N; Yi MD; Poon E; Alam M
Arch Dermatol Res; 2023 Jul; 315(5):1099-1108. PubMed ID: 36454335
[TBL] [Abstract][Full Text] [Related]
18. Current treatments of actinic keratosis.
Gold MH; Nestor MS
J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877
[TBL] [Abstract][Full Text] [Related]
19. Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness.
Emmerich VK; Cull D; Kelly KA; Feldman SR
J Dermatolog Treat; 2022 Jun; 33(4):2075-2078. PubMed ID: 33947303
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.
Samrao A; Cockerell CJ
Am J Clin Dermatol; 2013 Aug; 14(4):273-7. PubMed ID: 23640424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
